The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
Chemical Compound Review

Ac-Asp-OH     (2S)-2-acetamidobutanedioic acid

Synonyms: PubChem18990, CCRIS 9429, AG-C-33189, AG-I-02408, CHEMBL1162494, ...
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of N-Acetyl-L-aspartic acid


Psychiatry related information on N-Acetyl-L-aspartic acid


High impact information on N-Acetyl-L-aspartic acid


Chemical compound and disease context of N-Acetyl-L-aspartic acid


Biological context of N-Acetyl-L-aspartic acid


Anatomical context of N-Acetyl-L-aspartic acid


Associations of N-Acetyl-L-aspartic acid with other chemical compounds


Gene context of N-Acetyl-L-aspartic acid


Analytical, diagnostic and therapeutic context of N-Acetyl-L-aspartic acid


  1. Reduced levels of N-acetylaspartate in malignant brain tumors. McConnell, J.R. CA: a cancer journal for clinicians. (1999) [Pubmed]
  2. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Kaul, R., Gao, G.P., Balamurugan, K., Matalon, R. Nat. Genet. (1993) [Pubmed]
  3. Quantitative neuropathology by high resolution magic angle spinning proton magnetic resonance spectroscopy. Cheng, L.L., Ma, M.J., Becerra, L., Ptak, T., Tracey, I., Lackner, A., González, R.G. Proc. Natl. Acad. Sci. U.S.A. (1997) [Pubmed]
  4. Imaging of axonal damage in multiple sclerosis: spatial distribution of magnetic resonance imaging lesions. Narayanan, S., Fu, L., Pioro, E., De Stefano, N., Collins, D.L., Francis, G.S., Antel, J.P., Matthews, P.M., Arnold, D.L. Ann. Neurol. (1997) [Pubmed]
  5. Measurement of regional N-acetylaspartate after transient global ischemia in gerbils with and without ischemic tolerance: an index of neuronal survival. Nakano, M., Ueda, H., Li, J.Y., Matsumoto, M., Yanagihara, T. Ann. Neurol. (1998) [Pubmed]
  6. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Ende, G., Braus, D.F., Walter, S., Weber-Fahr, W., Henn, F.A. Arch. Gen. Psychiatry (2000) [Pubmed]
  7. Axonal injury within language network in primary progressive aphasia. Catani, M., Piccirilli, M., Cherubini, A., Tarducci, R., Sciarma, T., Gobbi, G., Pelliccioli, G., Petrillo, S.M., Senin, U., Mecocci, P. Ann. Neurol. (2003) [Pubmed]
  8. N-Acetylaspartate concentration in the anterior cingulate of maltreated children and adolescents with PTSD. De Bellis, M.D., Keshavan, M.S., Spencer, S., Hall, J. The American journal of psychiatry. (2000) [Pubmed]
  9. Working memory deficits and levels of N-acetylaspartate in patients with schizophreniform disorder. Bertolino, A., Sciota, D., Brudaglio, F., Altamura, M., Blasi, G., Bellomo, A., Antonucci, N., Callicott, J.H., Goldberg, T.E., Scarabino, T., Weinberger, D.R., Nardini, M. The American journal of psychiatry. (2003) [Pubmed]
  10. Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer. Mesters, J.R., Barinka, C., Li, W., Tsukamoto, T., Majer, P., Slusher, B.S., Konvalinka, J., Hilgenfeld, R. EMBO J. (2006) [Pubmed]
  11. Gray and white matter brain chemistry in young children with autism. Friedman, S.D., Shaw, D.W., Artru, A.A., Dawson, G., Petropoulos, H., Dager, S.R. Arch. Gen. Psychiatry (2006) [Pubmed]
  12. Prediction of functional outcome 18 months after a first psychotic episode: a proton magnetic resonance spectroscopy study. Wood, S.J., Berger, G.E., Lambert, M., Conus, P., Velakoulis, D., Stuart, G.W., Desmond, P., McGorry, P.D., Pantelis, C. Arch. Gen. Psychiatry (2006) [Pubmed]
  13. From the Cover: Structure of aspartoacylase, the brain enzyme impaired in Canavan disease. Bitto, E., Bingman, C.A., Wesenberg, G.E., McCoy, J.G., Phillips, G.N. Proc. Natl. Acad. Sci. U.S.A. (2007) [Pubmed]
  14. Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques. Arnold, D.L., Matthews, P.M., Francis, G.S., O'Connor, J., Antel, J.P. Ann. Neurol. (1992) [Pubmed]
  15. Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities. Chang, L., Ernst, T., Speck, O., Grob, C.S. The American journal of psychiatry. (2005) [Pubmed]
  16. A proton MRSI study of brain N-acetylaspartate level after 12 weeks of citalopram treatment in drug-naive patients with obsessive-compulsive disorder. Jang, J.H., Kwon, J.S., Jang, D.P., Moon, W.J., Lee, J.M., Ha, T.H., Chung, E.C., Kim, I.Y., Kim, S.I. The American journal of psychiatry. (2006) [Pubmed]
  17. Effect of hypoxia on cerebral metabolites measured by proton nuclear magnetic resonance spectroscopy in rats. Rosenberg, G.A., White, J., Gasparovic, C., Crisostomo, E.A., Griffey, R.H. Stroke (1991) [Pubmed]
  18. Elevated subcortical choline metabolites in cognitively and clinically asymptomatic HIV+ patients. Meyerhoff, D.J., Bloomer, C., Cardenas, V., Norman, D., Weiner, M.W., Fein, G. Neurology (1999) [Pubmed]
  19. Variation in GRM3 affects cognition, prefrontal glutamate, and risk for schizophrenia. Egan, M.F., Straub, R.E., Goldberg, T.E., Yakub, I., Callicott, J.H., Hariri, A.R., Mattay, V.S., Bertolino, A., Hyde, T.M., Shannon-Weickert, C., Akil, M., Crook, J., Vakkalanka, R.K., Balkissoon, R., Gibbs, R.A., Kleinman, J.E., Weinberger, D.R. Proc. Natl. Acad. Sci. U.S.A. (2004) [Pubmed]
  20. Sex differences in N-acetylaspartate correlates of general intelligence: an 1H-MRS study of normal human brain. Jung, R.E., Haier, R.J., Yeo, R.A., Rowland, L.M., Petropoulos, H., Levine, A.S., Sibbitt, W.L., Brooks, W.M. Neuroimage (2005) [Pubmed]
  21. Association of human hippocampal neurochemistry, serotonin transporter genetic variation, and anxiety. Gallinat, J., Ströhle, A., Lang, U.E., Bajbouj, M., Kalus, P., Montag, C., Seifert, F., Wernicke, C., Rommelspacher, H., Rinneberg, H., Schubert, F. Neuroimage (2005) [Pubmed]
  22. Is ischemia involved in the pathogenesis of murine cerebral malaria? Sanni, L.A., Rae, C., Maitland, A., Stocker, R., Hunt, N.H. Am. J. Pathol. (2001) [Pubmed]
  23. Restoration of aspartoacylase activity in CNS neurons does not ameliorate motor deficits and demyelination in a model of Canavan disease. Klugmann, M., Leichtlein, C.B., Symes, C.W., Serikawa, T., Young, D., During, M.J. Mol. Ther. (2005) [Pubmed]
  24. Defective N-acetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan's disease. Madhavarao, C.N., Arun, P., Moffett, J.R., Szucs, S., Surendran, S., Matalon, R., Garbern, J., Hristova, D., Johnson, A., Jiang, W., Namboodiri, M.A. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  25. Hippocampal N-acetylaspartate in neocortical epilepsy and mesial temporal lobe epilepsy. Vermathen, P., Ende, G., Laxer, K.D., Knowlton, R.C., Matson, G.B., Weiner, M.W. Ann. Neurol. (1997) [Pubmed]
  26. N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve. Bjartmar, C., Battistuta, J., Terada, N., Dupree, E., Trapp, B.D. Ann. Neurol. (2002) [Pubmed]
  27. Interdependence of N-acetyl aspartate and high-energy phosphates in healthy human brain. Pan, J.W., Takahashi, K. Ann. Neurol. (2005) [Pubmed]
  28. Magnetic resonance spectroscopy of N-acetylaspartate in hypoxic-ischemic encephalopathy. Graham, S.H., Meyerhoff, D.J., Bayne, L., Sharp, F.R., Weiner, M.W. Ann. Neurol. (1994) [Pubmed]
  29. N-Acetylaspartylglutamate: possible role as the neurotransmitter of the lateral olfactory tract. Ffrench-Mullen, J.M., Koller, K., Zaczek, R., Coyle, J.T., Hori, N., Carpenter, D.O. Proc. Natl. Acad. Sci. U.S.A. (1985) [Pubmed]
  30. Childhood ataxia with diffuse central nervous system hypomyelination. Schiffmann, R., Moller, J.R., Trapp, B.D., Shih, H.H., Farrer, R.G., Katz, D.A., Alger, J.R., Parker, C.C., Hauer, P.E., Kaneski, C.R. Ann. Neurol. (1994) [Pubmed]
  31. Chemical pathology of acute demyelinating lesions and its correlation with disability. De Stefano, N., Matthews, P.M., Antel, J.P., Preul, M., Francis, G., Arnold, D.L. Ann. Neurol. (1995) [Pubmed]
  32. Role of collateral flow on cerebral hemodynamics in patients with unilateral internal carotid artery occlusion. van Everdingen, K.J., Visser, G.H., Klijn, C.J., Kappelle, L.J., van der Grond, J. Ann. Neurol. (1998) [Pubmed]
  33. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Théberge, J., Al-Semaan, Y., Williamson, P.C., Menon, R.S., Neufeld, R.W., Rajakumar, N., Schaefer, B., Densmore, M., Drost, D.J. The American journal of psychiatry. (2003) [Pubmed]
  34. Murine aspartoacylase: cloning, expression and comparison with the human enzyme. Namboodiri, M.A., Corigliano-Murphy, A., Jiang, G., Rollag, M., Provencio, I. Brain Res. Mol. Brain Res. (2000) [Pubmed]
  35. NGF, BDNF and NT-5, but not NT-3 protect against MPP+ toxicity and oxidative stress in neonatal animals. Kirschner, P.B., Jenkins, B.G., Schulz, J.B., Finkelstein, S.P., Matthews, R.T., Rosen, B.R., Beal, M.F. Brain Res. (1996) [Pubmed]
  36. Magnetic resonance spectroscopy and analysis of MECP2 in Rett syndrome. Khong, P.L., Lam, C.W., Ooi, C.G., Ko, C.H., Wong, V.C. Pediatric neurology. (2002) [Pubmed]
  37. Reduced N-acetylaspartate levels in mice lacking aralar, a brain- and muscle-type mitochondrial aspartate-glutamate carrier. Jalil, M.A., Begum, L., Contreras, L., Pardo, B., Iijima, M., Li, M.X., Ramos, M., Marmol, P., Horiuchi, M., Shimotsu, K., Nakagawa, S., Okubo, A., Sameshima, M., Isashiki, Y., Del Arco, A., Kobayashi, K., Satrústegui, J., Saheki, T. J. Biol. Chem. (2005) [Pubmed]
  38. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis. Arnold, D.L., Riess, G.T., Matthews, P.M., Francis, G.S., Collins, D.L., Wolfson, C., Antel, J.P. Ann. Neurol. (1994) [Pubmed]
  39. Use of computed tomography, magnetic resonance imaging, and localized 1H magnetic resonance spectroscopy in Canavan's disease: a case report. Marks, H.G., Caro, P.A., Wang, Z.Y., Detre, J.A., Bogdan, A.R., Gusnard, D.A., Zimmerman, R.A. Ann. Neurol. (1991) [Pubmed]
  40. Functional 1H-MRS findings in migraine patients with and without aura assessed interictally. Sarchielli, P., Tarducci, R., Presciutti, O., Gobbi, G., Pelliccioli, G.P., Stipa, G., Alberti, A., Capocchi, G. Neuroimage (2005) [Pubmed]
WikiGenes - Universities